A monoclonal antibody to the interleukin-2 receptor enhances the survival of neural allografts: a time-course study.

A monoclonal antibody to the interleukin-2 receptor enhances the survival of neural allografts: a time-course study.

A time-course study of the survival and immunological characteristics of rat neural allografts was undertaken in animals treated with a murine monoclonal antibody to the alpha-chain (p55) of the rat interleukin-2 receptor. This antibody, NDS 63, was administered for ten days following grafting begin...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Wood, M, Sloan, D, Dallman, M, Charlton, H
Format:	Journal article
Sprache:	English
Veröffentlicht:	1992

Ähnliche Einträge

Specific tolerance to neural allografts induced with an antibody to the interleukin 2 receptor.
von: Wood, M, et al.
Veröffentlicht: (1993)

Indefinite survival of neural xenografts induced with anti-CD4 monoclonal antibodies.
von: Wood, M, et al.
Veröffentlicht: (1996)

Nondepleting anti-CD4 monoclonal antibody enhances the ability of oral alloantigen delivery to induce indefinite survival of cardiac allografts: oral tolerance to alloantigen.
von: Niimi, M, et al.
Veröffentlicht: (2000)

Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
von: Naparstek, E, et al.
Veröffentlicht: (1999)

Monoclonal antibody targeting of CD4(+) and CD8(+) cells for prolongation of baboon renal allograft survival.
von: Hazinedaroglu, S, et al.
Veröffentlicht: (2005)

Delayed allograft rejection in primates treated with anti-IL-2 receptor monoclonal antibody Campath-6.
von: Tighe, H, et al.
Veröffentlicht: (1988)

CD4 and CD8 monoclonal antibody therapy: strategies to prolong renal allograft survival in the dog.
von: Watson, C, et al.
Veröffentlicht: (1993)

Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis.
von: Kyle, V, et al.
Veröffentlicht: (1989)

NEW OPPORTUNITIES OF TREATMENT OF DIFFERENT TYPES OF JUVENILE ARTHRITIS WITH MONOCLONAL ANTIBODIES TO THE INTERLEUKIN 6 RECEPTOR
von: E.I. Alexeeva, et al.
Veröffentlicht: (2010-01-01)

NEW OPPORTUNITIES OF TREATMENT OF DIFFERENT TYPES OF JUVENILE ARTHRITIS WITH MONOCLONAL ANTIBODIES TO THE INTERLEUKIN 6 RECEPTOR
von: E.I. Alexeeva, et al.
Veröffentlicht: (2010-01-01)

CD4 monoclonal antibodies in the preclinical dog renal allograft model.
von: Watson, C, et al.
Veröffentlicht: (1993)

Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
von: Friend, P, et al.
Veröffentlicht: (1991)

Tolerability of Sarilumab – An anti-interleukin-6 receptor monoclonal antibody is controversial for the management of COVID-19
von: Justin Jacob Abraham, et al.
Veröffentlicht: (2021-01-01)

Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody.
von: Friend, P, et al.
Veröffentlicht: (1995)

CD4 and CD8 monoclonal antibody therapy in canine renal allografts.
von: Watson, C, et al.
Veröffentlicht: (1994)

The use of monoclonal antibodies against activated human T cells following renal allografting in the baboon.
von: Friend, P, et al.
Veröffentlicht: (1987)

Monoclonal Antibodies to the Thyrotropin Receptor
von: Takao Ando, et al.
Veröffentlicht: (2005-01-01)

Oral delivery of alloantigen combined with non-depleting anti-CD4 monoclonal antibody induces indefinite survival of cardiac allografts and generates CD4(+) regulatory T cells.
von: Niimi, M, et al.
Veröffentlicht: (2000)

Use of Anti-Interleukin-6 Receptor Monoclonal Antibody in Drug-Induced Acute Respiratory Distress Syndrome
von: Alessandra Petrillo, et al.
Veröffentlicht: (2020-01-01)

Siltuximab - A monoclonal antibody against the interleukin-6 receptor is not an ideal option for management of COVID-19
von: I Jerlin Michelle, et al.
Veröffentlicht: (2021-01-01)

New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)
von: Evgeniy L'vovich Nasonov, et al.
Veröffentlicht: (2010-05-01)

Production, selection, and testing of monoclonal antibodies to canine leukocytes in the dog kidney allograft model.
von: Davies, H, et al.
Veröffentlicht: (1994)

Immunosuppression of canine renal allograft recipients by CD4 and CD8 monoclonal antibodies.
von: Watson, C, et al.
Veröffentlicht: (1994)

The efficacy and safety of sarilumab, fully human monoclonal antibodies against interleukin 6 receptor, in rheumatoid arthritis: new evidence
von: E. L. Nasonov, et al.
Veröffentlicht: (2019-11-01)

Effect of graft perfusion with two CD45 monoclonal antibodies on incidence of kidney allograft rejection.
von: Brewer, Y, et al.
Veröffentlicht: (1989)

Experience with the use of recombinant humanized monoclonal antibodies to the human receptor for interleukin-6 in patients with CoVID-19
von: D. А. Gusev, et al.
Veröffentlicht: (2020-08-01)

Severe hypereosinophilic syndrome successfully treated with a monoclonal antibody against interleukin 5 receptor α – benralizumab
von: Joanna Kosałka-Węgiel, et al.
Veröffentlicht: (2021-08-01)

Research Note: Development and characterization of monoclonal antibodies specific for chicken interleukin-7 receptor α (CD127)
von: Zhifeng Sun, et al.
Veröffentlicht: (2022-10-01)

Changes in Iron Metabolism Induced by Anti-Interleukin-6 Receptor Monoclonal Antibody are Associated with an Increased Risk of Infection
von: Renata Ribeiro, et al.
Veröffentlicht: (2019-06-01)

Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19
von: Steven Douedi, et al.
Veröffentlicht: (2020-01-01)

Immunosuppression with monoclonal antibodies in neural transplantation
von: Honey, C
Veröffentlicht: (1990)

De Novo AL Amyloidosis in Renal Allograft and Anti-CD38 Monoclonal Antibody Treatment
von: Despina Fotiou, et al.
Veröffentlicht: (2021-12-01)

Binding of monoclonal anti-interleukin 2 antibody to nucleoli in acute leukemia blast cells.
von: Schwonzen, M, et al.
Veröffentlicht: (1992)

Oral administration of alloantigen plus nondepleting anti-CD4 monoclonal antibody induces indefinite prolongation of fully allogeneic cardiac allografts.
von: Niimi, M, et al.
Veröffentlicht: (2000)

A meta-analysis of anti-interleukin-13 monoclonal antibodies for uncontrolled asthma.
von: Hang Li, et al.
Veröffentlicht: (2019-01-01)

SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody
von: Collin Jugler, et al.
Veröffentlicht: (2021-11-01)

The immune response to intracerebral neural grafts.
von: Sloan, D, et al.
Veröffentlicht: (1991)

Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33
von: Okragly AJ, et al.
Veröffentlicht: (2021-08-01)

CD4 and CD8 monoclonal antibody therapy in the dog: strategies to induce tolerance to renal allografts.
von: Watson, C, et al.
Veröffentlicht: (1995)

Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.
von: Cobbold, S, et al.
Veröffentlicht: (1990)